Chimerix to Report Second Quarter 2024 Financial Results and Provide an Operational Update on August 13, 2024
Chimerix (NASDAQ:CMRX), a biopharmaceutical company focused on developing medicines for deadly diseases, has announced it will host a live conference call and audio webcast on August 13, 2024, at 8:30 a.m. ET. The purpose of this event is to report financial results for the second quarter ended June 30, 2024, and provide a business overview.
Interested parties can access the call by dialing (646) 307-1963 (domestic) or (800) 715-9871 (international) and referring to conference ID 5436125. A live audio webcast will be available on the Investors' section of Chimerix's website, with an archived version accessible approximately two hours after the event.
Chimerix (NASDAQ:CMRX), una azienda biofarmaceutica focalizzata nello sviluppo di medicinali per malattie letali, ha annunciato che ospiterà una conferenza telefonica in diretta e un audio webcast il 13 agosto 2024, alle 8:30 ora Eastern. Lo scopo di questo evento è di riportare i risultati finanziari per il secondo trimestre conclusosi il 30 giugno 2024 e fornire una panoramica aziendale.
Le parti interessate possono accedere alla chiamata componendo il numero (646) 307-1963 (nazionale) o (800) 715-9871 (internazionale) e facendo riferimento all'ID conferenza 5436125. Un audio webcast in diretta sarà disponibile nella sezione Investitori del sito web di Chimerix, con una versione archiviata accessibile circa due ore dopo l'evento.
Chimerix (NASDAQ:CMRX), una compañía biofarmacéutica enfocada en desarrollar medicamentos para enfermedades mortales, ha anunciado que llevará a cabo una videoconferencia en vivo y audio webcast el 13 de agosto de 2024, a las 8:30 a.m. ET. El propósito de este evento es informar sobre los resultados financieros del segundo trimestre que finalizó el 30 de junio de 2024 y proporcionar una visión general del negocio.
Las partes interesadas pueden acceder a la llamada marcando (646) 307-1963 (nacional) o (800) 715-9871 (internacional) y refiriéndose al ID de conferencia 5436125. Un audio webcast en vivo estará disponible en la sección de Inversores del sitio web de Chimerix, con una versión archivada accesible aproximadamente dos horas después del evento.
Chimerix (NASDAQ:CMRX)는 치명적인 질병을 위한 의약품 개발에 집중하는 바이오 제약 회사로, 2024년 8월 13일, 오전 8:30 ET에 생중계 컨퍼런스 콜 및 오디오 웹캐스트를 개최한다고 발표했습니다. 이번 이벤트의 목적은 2024년 6월 30일자로 종료된 두 번째 분기 재무 결과를 보고하고 비즈니스 개요를 제공하는 것입니다.
관심이 있는 분들은 (646) 307-1963(국내) 또는 (800) 715-9871(국제)로 전화하여 컨퍼런스 ID 5436125를 언급하시면 됩니다. 생중계 오디오 웹캐스트는 Chimerix 웹사이트의 투자자 섹션에서 제공되며, 이벤트 종료 약 두 시간 후에 아카이브된 버전도 이용 가능합니다.
Chimerix (NASDAQ:CMRX), une entreprise biopharmaceutique axée sur le développement de médicaments pour des maladies mortelles, a annoncé qu'elle tiendra un appel conférence en direct et un audio webcast le 13 août 2024 à 8h30, heure de l'Est. L'objectif de cet événement est de rapporter les résultats financiers du deuxième trimestre terminé le 30 juin 2024 et de fournir un aperçu de l'entreprise.
Les parties intéressées peuvent accéder à l'appel en composant le (646) 307-1963 (national) ou le (800) 715-9871 (international) et en se référant à l'ID de conférence 5436125. Un audio webcast en direct sera disponible dans la section Investisseurs du site Web de Chimerix, avec une version archivée accessible environ deux heures après l'événement.
Chimerix (NASDAQ:CMRX), ein bio-pharmazeutisches Unternehmen, das sich auf die Entwicklung von Medikamenten gegen tödliche Krankheiten spezialisiert hat, hat angekündigt, am 13. August 2024 um 8:30 Uhr ET eine Live-Konferenzschaltung und Audio-Webcast abzuhalten. Zweck dieser Veranstaltung ist es, die Finanzergebnisse des zweiten Quartals, das am 30. Juni 2024 endete, zu berichten und einen Überblick über das Unternehmen zu geben.
Interessierte Parteien können die Konferenz unter der Nummer (646) 307-1963 (inländisch) oder (800) 715-9871 (international) erreichen und auf die Konferenz-ID 5436125 verweisen. Ein Live-Audio-Webcast wird im Investorenbereich der Webseite von Chimerix verfügbar sein, und eine archivierte Version wird etwa zwei Stunden nach der Veranstaltung zugänglich sein.
- None.
- None.
DURHAM, N.C., Aug. 06, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that it will host a live conference call and audio webcast on Tuesday, August 13, 2024 at 8:30 a.m. ET to report financial results for the second quarter ended June 30, 2024, and to provide a business overview.
To access the live conference call, please dial (646) 307-1963 (domestic) or (800) 715-9871 (international) at least five minutes prior to the start time, and refer to conference ID 5436125. A live audio webcast of the call will also be available on the Investors’ section of the Company's website, www.chimerix.com. An archived webcast will be available on the Chimerix website approximately two hours after the event.
About Chimerix
Chimerix is a biopharmaceutical company with a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The Company’s most advanced clinical-stage development program, ONC201, is in development for H3 K27M-mutant glioma.
CONTACT:
Will O’Connor
Stern Investor Relations
212-362-1200
will@sternir.com
FAQ
When will Chimerix (CMRX) report its Q2 2024 financial results?
How can investors access Chimerix's (CMRX) Q2 2024 earnings call?
What period will Chimerix's (CMRX) Q2 2024 financial results cover?
Where can I find the archived webcast of Chimerix's (CMRX) Q2 2024 earnings call?
